Engineering Enzymes for the Biomanufacture of Nucleoside Conjugates

Updated: about 2 months ago
Location: Gaithersburg, MARYLAND
Deadline: The position may have been removed or expired!

RAP opportunity at National Institute of Standards and Technology     NIST

Engineering Enzymes for the Biomanufacture of Nucleoside Conjugates


Location

Material Measurement Laboratory, Biomolecular Measurement Division


opportunity location
50.64.51.B7943 Gaithersburg, MD

NIST only participates in the February and August reviews.


Advisers
name email phone
Zvi Kelman [email protected] 240.314.294
Description

Nucleoside analogues are widely used as antiviral and antitumor drugs by blocking the activity of DNA or RNA polymerases. An archaeal enzyme that converts a nucleotide triphosphate (NTP) to a nucleotide monophosphate (NMP)-small molecule (SM) adduct via formation of a NMP-O-R or a NMP-N-R linkage was recently identified in the laboratory. While the biological significance of this activity is unknown, its utility as a potentially inexpensive and bio-friendly method for biomanufacturing nucleoside analog “pro-drugs” is being explored. Ongoing research focuses on determining the efficiency and selectivity of the enzyme reaction by exploring the chemical space of SMs (i.e., sugars, lipids, amino acids) as well as nucleoside analogues (i.e., ddNTPs) that can used by the enzyme as substrates to generate NMP-SM.

References

Galal WC, Pan M, Kelman Z, Hurwitz J: Journal of Biological Chemistry 287: 16209, 2012

Galal WC, et al: Journal of Biological Chemistry 287: 16220, 2012


key words

Antiviral drugs; Anticancer drugs; Nucleoside analogues; Primase;


Eligibility

citizenship

Open to U.S. citizens


level

Open to Postdoctoral applicants


Stipend
Base Stipend Travel Allotment Supplementation
$102,415.00 $3,000.00

Similar Positions